X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global Single-cell Genome Sequencing Companies

This report lists the top Global Single-cell Genome Sequencing companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Single-cell Genome Sequencing industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Global Single-cell Genome Sequencing Top Companies

  1. QIAGEN 

  2. Fluidigm

  3. Illumina

  4. Roche

  5. Thermo Fisher Scientific

*Disclaimer: Top companies sorted in no particular order

Global Single-cell Genome Sequencing Market Major Players

Global Single-cell Genome Sequencing Market Concentration

Global Single-cell Genome Sequencing  Market Concentration

Global Single-cell Genome Sequencing Company List

                              • 10x Genomics

                              • BD

                              • BGI

                              • Bio-Rad Laboratories, Inc.

                              • F. Hoffmann-La Roche Ltd.

                              • Fluidigm Corporation

                              • Illumina, Inc.

                              • Oxford Nanopore Technologies plc.

                              • PacBio

                              • QIAGEN

                              • Takara Bio Inc

                              • ThermoFisher Scientific, Inc.


                          Specific to Global Single-cell Genome Sequencing Market
                          Need More Details On Market Players And Competitors?
                          Download PDF

                          Single-cell Genome Sequencing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)